Cipla Chief Says India Makers Need A Decade To Compete With New Drugs
This article was originally published in PharmAsia News
Executive Summary
Cipla's chairman said India would not be able to reach the level of developed markets in the ability to compete with innovative drugs for at least 11 more years, possibly in 2025.